Inflacam

1 x 100 ml

Oral Suspension

Active substance

Meloxicam : 15 mg/ml

ATC code

QM01AC06 Meloxicam

QM01AC Oxicams

QM01A Antiinflammatory and antirheumatic products, non-steroids (NSAIDs)

QM01 Antiinflammatory and antirheumatic products

QM Musculo-skeletal system

Species

Horses.

Indications

Alleviation of inflammation and relief of pain in both acute and chronic musculo-skeletal disorders in horses.

Dose to be administered and administration route

To be administered either mixed with food or directly into the mouth at a dosage of 0.6 mg/kg body weight, once daily, up to 14 days. In case the veterinary medicinal product is mixed with food, it should be added to a small quantity of food, prior to feeding.

The suspension should be given using the measuring syringe provided in the package of the veterinary medicinal product. The syringe fits onto the bottle and has a 2 ml scale.

To ensure a correct dosage, body weight should be determined as accurately as possible. The use of suitably calibrated measuring equipment is recommended.

Shake well before use.

After administration of the veterinary medicinal product, close the bottle by replacing the cap, wash the measuring syringe with warm water and let it dry.

Avoid introduction of contamination during use.

Adverse reactions

Horses:

Very rare

(<1 animal / 10,000 animals treated, including isolated reports):

Appetite loss, Lethargy

Diarrhoea¹, Abdominal pain, Colitis.

Urticaria^1,2, Anaphylactoid reaction³.

¹Reversible

²Slight

³May be serious (including fatal). If such reaction occurs, it should be treated symptomatically.

If adverse reactions occur, treatment should be discontinued and the advice of a veterinarian should be sought.

Reporting adverse events is important. It allows continuous safety monitoring of a veterinary medicinal product. Reports should be sent, preferably via a veterinarian, to either the marketing authorisation holder or its local representative or the national competent authority via the national reporting system. See also the package leaflet for respective contact details.